Get in touch
Proven Connect aims to support the commercialisation of prostate cancer innovations through investment, expertise in academic and translational research and a deep understanding of patient needs.
Get in touch
We are particularly interested in hearing from companies an innovative / novel product in early-stage Development and strong pre-clinical or early trial data with the potential to…
- Improve screening (more accurate diagnosis/prognosis)
- Provide for better disease management
- Improve drug development and clinical trial success
- Deliver earlier efficacious treatments with fewer side effects
We welcome applications from academics looking to spin out and start ups and offer direct support and advice through the application process.
We operate a rolling programme for applications with decisions taking 8-10 weeks from submission. Typically, investment size is between £50,000 – £200,000. If your investment needs exceed this, please get in touch about joining our portfolio.
Successful applicants benefit from access to:
- Mentorship – AZ
- Clinical advice
- Patient insight
- Business model development
- Follow on funding opportunities
(downloads – application form)
Link to get in touch